Head and neck cancer patients who were given smartphone and sensor technology as a way to remotely monitor their symptoms reported less severe symptoms from their cancer and treatment than their counterparts who did receive the technology, according to a recent study presented at the American Society of Clinical Oncology annual meeting.
from MobiHealthNews https://ift.tt/2LeRyK3
May 18, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Workplace safety app maker SafetyCulture closes $45.4M investmentSafetyCulture, an Australian developer of apps designed to reduce and report employees’ workplace injuries, announced that it has completed a $45.4 million (60 million Australian dollars) funding round led by Tiger Global Man… Read More
Blink Health alleges MedImpact improperly steers patients toward opioidsThis week Blink Health, which makes an app and online tool for helping consumers find low prices for medications, filed a new legal claim against former partner MedImpact Healthcare System alleging greed and misconduct w… Read More
Alphabet's GV invests $7 million in AI startup OwkinNew York City-based Owkin, which uses machine learning to enhance biomedical research, has raised $7 million in Series A follow-on funds. GV, the venture arm of Alphabet formerly known as Google Ventures, was the sole investo… Read More
Health outcomes AI company OM1 lands $21M in Series B fundingBoston-based health outcomes and tech company OM1 has just announced that it raked in $21 million in a Series B financing round led by Polaris Partners with participation from existing investors including General Ca… Read More
Virtual, in-person visits lead to similar blood pressure control for hypertension patientsA recent study of hypertension patients suggests follow-up visits conducted virtually are just as effective in maintaining blood pressure control as those conducted in person. Conducted by researchers at the Massachusetts Gen… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment